Full form of ZIFT is Zygote Intrafallopian Transfer. It is a form of assisted reproduction technology (ART). It supports those who are infertile in conceiving a child. In vitro fertilisation (IVF) and gamete intrafallopian transfer (GIFT) methods were combined to create the hybrid technique known as ZIFT. It differs from IVF as the zygote in ZIFT is transferred to the fallopian tube, whereas in IVF, then the zygote is transferred to the uterus. It is not recommended for women who have abnormal uterine tubes.
In comparison to IVF cycles, which had pregnancy and implantation rates of 17.5 and 9.7%, ZIFT cycles had pregnancy and implantation rates of 52.3 and 23.2%.
The normal ZIFT cycle lasts between five and six weeks to complete. Clomiphene, a fertility drug, is first used by the female to increase egg production in the ovaries.
When the ovarian follicles have reached maturity, the doctor will administer an injection of human chorionic gonadotropins to the patient (HCG or hCG).
About 36 hours later, the eggs will be collected, typically through transvaginal ovum retrieval.
The early embryos or zygotes produced by laboratory fertilisation are then inserted into the woman's fallopian tubes.
A woman should have a healthy fallopian tube where the zygote can be implanted.
Tubal obstruction.
Severe tubal injury.
Uterine anatomic conditions.
Sperm that can not get through an egg.
ZIFT was first used in 1986.
Tubal embryo transfer is the other name for ZIFT.
When any type of blockage in the fallopian tube prevents the sperm from reaching the egg, then ZIFT is used.
A Laparoscopy method is used to transfer the zygote to the fallopian tube.
A person undergoing ZIFT can experience nausea, vomiting and an upset stomach.